Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced Senescence

Mikhail A Nikiforov1, Donna S Shewach2

  • 1Department of Cell Stress Biology, Roswell Park Cancer Institute, BLSC L3-317, Elm & Carlton Streets, Buffalo, NY, 14263, USA. Mikhail.Nikiforov@Roswellpark.org.

Insights

Oncogene-induced senescence involves DNA damage due to depleted deoxyribonucleotides. Measuring these nucleotide pools in senescent cells is crucial for understanding this process.

Area of Science:

  • Cellular senescence
  • DNA damage response
  • Oncogene signaling

Background:

  • Activated oncogenes trigger senescence phenotypes in normal human cells via DNA damage response.
  • Depletion of intracellular deoxyribonucleotide pools is a key cause of DNA damage during oncogene-induced senescence.
  • Decreased expression of thymidylate synthase (TS) and ribonucleotide reductase (RR) contributes to deoxyribonucleotide pool depletion.

Purpose of the Study:

  • To describe a methodology for quantitatively measuring nucleotide pools in senescent cells.
  • To investigate the role of deoxyribonucleotide pool depletion in oncogene-induced senescence.

Main Methods:

  • Quantitative measurement of intracellular deoxyribonucleotide pools.
  • Analysis of thymidylate synthase (TS) and ribonucleotide reductase (RR) expression.
  • Induction of senescence using activated HRAS or C-MYC depletion.

Main Results:

  • Depletion of TS or RR individually induces premature senescence.
  • Ectopic expression of TS and RR suppresses senescence phenotypes.
  • Addition of deoxyribonucleosides also suppresses senescence phenotypes.

Conclusions:

  • Deoxyribonucleotide pool depletion is a critical mechanism driving oncogene-induced senescence.
  • Targeting nucleotide biosynthesis pathways may offer therapeutic strategies for senescence-related conditions.
  • Accurate measurement of nucleotide pools is essential for studying senescence.